InsidersTradesSigma
Explore the full record of transactions filed by 이권선, Chief Executive Officer. Officer active across 2 companies, notably 셀바이오휴먼텍. Aggregated, 4 disclosures have been published. The latest transaction was disclosed on 1 April 2026 — Purchase. Regulator: DART (FSS). All data is accessible without signup.
4 of 4 declarations
Lee Gwon-seon is the CEO of Cellbio Human Tech, an innovative company in the biotechnology sector. He is responsible for the strategic direction and management of operations. His leadership is essential for the development and growth of the company.